Workflow
Cibus(CBUS) - 2025 Q1 - Quarterly Report
CBUSCibus(CBUS)2025-05-08 20:35

Financial Performance - Total revenue for Q1 2025 was 1,034,000,a901,034,000, a 90% increase from 545,000 in Q1 2024[23] - Net loss for Q1 2025 was 49,392,000,comparedtoanetlossof49,392,000, compared to a net loss of 26,972,000 in Q1 2024, indicating a worsening financial position[23] - Basic and diluted net loss per share of Class A common stock was 1.34forQ12025,comparedto1.34 for Q1 2025, compared to 1.12 for Q1 2024[23] - Cibus, Inc. reported a net loss of 49,392,000forthethreemonthsendedMarch31,2025,comparedtoanetlossof49,392,000 for the three months ended March 31, 2025, compared to a net loss of 26,972,000 for the same period in 2024, indicating an increase in losses of approximately 83.5% year-over-year[30] - The total segment loss for the three months ended March 31, 2025, was (49,392,000),comparedto(49,392,000), compared to (26,972,000) in 2024, indicating a loss increase of 83.1%[84] Operating Expenses - Operating expenses for Q1 2025 totaled 42,605,000,comparedto42,605,000, compared to 18,998,000 in Q1 2024, reflecting a significant increase due to goodwill impairment of 20,950,000[23]TotaloperatingexpensesforthethreemonthsendedMarch31,2025,were20,950,000[23] - Total operating expenses for the three months ended March 31, 2025, were 42,605,000, up from 18,998,000in2024,reflectinga124.418,998,000 in 2024, reflecting a 124.4% increase[84] - The company incurred a royalty liability interest expense of 8,377,000 related to parties during the first quarter of 2025, slightly up from 8,329,000intheprioryear[30]CashandAssetsCashandcashequivalentsincreasedto8,329,000 in the prior year[30] Cash and Assets - Cash and cash equivalents increased to 23,587,000 as of March 31, 2025, from 14,433,000asofDecember31,2024[21]Totalassetsdecreasedto14,433,000 as of December 31, 2024[21] - Total assets decreased to 335,045,000 as of March 31, 2025, down from 350,069,000asofDecember31,2024[21]AsofMarch31,2025,theCompanyhad350,069,000 as of December 31, 2024[21] - As of March 31, 2025, the Company had 23.6 million in cash and cash equivalents and 21.0millionincurrentliabilities[41]LiabilitiesTotalliabilitiesincreasedto21.0 million in current liabilities[41] Liabilities - Total liabilities increased to 261,088,000 as of March 31, 2025, compared to 252,238,000asofDecember31,2024[21]Thecompanyreportedaroyaltyliabilityof252,238,000 as of December 31, 2024[21] - The company reported a royalty liability of 207,819,000 as of March 31, 2025, up from 199,442,000asofDecember31,2024[21]TheRoyaltyLiabilityrelatedtopartiesincreasedto199,442,000 as of December 31, 2024[21] - The Royalty Liability related to parties increased to 207,819,000 from 199,442,000asofDecember31,2024,reflectinganeffectiveyieldof16.5199,442,000 as of December 31, 2024, reflecting an effective yield of 16.5%[145] Goodwill and Impairment - The company recognized a goodwill impairment of 20,950,000 during the first quarter of 2025, which was not present in the same quarter of 2024[30] - Goodwill impairment for the three months ending March 31, 2025, was 20,950,000,withtotalaccumulatedimpairmentlossesincreasingto20,950,000, with total accumulated impairment losses increasing to 352,750,000[103] Shareholder Information - The company had a total of 32,657,738 Class A common shares outstanding as of March 31, 2025, compared to 21,014,970 shares as of March 31, 2024, reflecting a significant increase in shares issued[28] - The weighted average shares of Class A common stock outstanding increased to 35,052,692 for the three months ended March 31, 2025, from 20,862,938 in 2024[74] Future Outlook - The company has not provided specific guidance for future performance, citing various risks and uncertainties in its operations[14] - The Company anticipates continued losses for the next several years and plans to finance future cash needs through various means, including commercialization activities and potential equity or debt financings[42] Stock-Based Compensation - Total stock-based compensation for the first quarter of 2025 was 2,499,000,comparedto2,499,000, compared to 2,528,000 in the same quarter of 2024[30] - The stock-based compensation expense for the three months ended March 31, 2025, was 232,000,comparedto232,000, compared to 19,000 for the same period in 2024[125] - Stock-based compensation expense related to RSAs decreased from 2,446,000inQ12024to2,446,000 in Q1 2024 to 1,840,000 in Q1 2025, with unrecognized compensation expense of 6.0millionremaining[129]RevenueRecognitionRevenueforthethreemonthsendedMarch31,2025,was6.0 million remaining[129] Revenue Recognition - Revenue for the three months ended March 31, 2025, was 1,034,000, compared to 545,000forthesameperiodin2024,representinganincreaseof89.5545,000 for the same period in 2024, representing an increase of 89.5%[84] - Revenue recognized from the collaboration agreement with Procter & Gamble increased significantly from 172,000 in Q1 2024 to 869,000inQ12025[148]LegalandComplianceTheCompanyhasaccruedanestimateof869,000 in Q1 2025[148] Legal and Compliance - The Company has accrued an estimate of 3.0 million for litigation liability based on a recent court decision, although it is not a party to any material pending legal proceedings[143] - The Company has not experienced any counterparty credit losses as of March 31, 2025, maintaining a diversified portfolio of high investment-grade securities[100]